Sign in
My Account
orders
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sign in / Join
My Account
orders
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Market Exclusive
My Account
orders
Home
Tags
NYSE:GSK
Tag: NYSE:GSK
Analyst Activity – Citigroup Inc. Reiterates Neutral on GlaxoSmithKline PLC (NYSE:GSK)
ME Staff
-
July 27, 2017
0
GlaxoSmithKline plc. (ADR)(NYSE:GSK) To Offload 130 Brands As Part of £1...
-
July 27, 2017
0
Analyst Activity – J P Morgan Chase & Co Reiterates Neutral...
ME Staff
-
July 24, 2017
0
Analyst Activity – J P Morgan Chase & Co Reiterates Neutral...
ME Staff
-
July 24, 2017
0
GlaxoSmithKline Plc (ADR) (NYSE:GSK) Reveals Plan To Sell Off Horlicks Brand
Andy Parker
-
July 20, 2017
0
GlaxoSmithKline plc. (ADR)(NYSE:GSK) Inks $43 Million Artificial Intelligence Deal To Develop...
-
July 5, 2017
0
Novartis AG (ADR) (NYSE:NVS) Enbrel Biosimilar Erelzi Approved In Europe
-
June 29, 2017
0
GlaxoSmithKline plc (ADR) (NYSE:GSK) Presents Positive Data From Phase III Shingles...
-
June 23, 2017
0
GlaxoSmithKline plc (ADR) (NYSE:GSK) To Receive $235M From Teva Pharmaceutical Industries...
Andy Parker
-
June 22, 2017
0
European Commission Clears Novartis AG (ADR) (NYSE:NVS) Blood Cancer Drug
Andy Parker
-
June 20, 2017
0
1
2
3
4
...
9
Page 3 of 9
/* */
// AST – IMS - [MarketExclusive_ROS]
Edit with Live CSS